Published in Diabetologia on August 01, 1996
Action for Health in Diabetes (Look AHEAD) trial: baseline evaluation of selected nutrients and food group intake. J Am Diet Assoc (2009) 1.30
Association of diet with glycated hemoglobin during intensive treatment of type 1 diabetes in the Diabetes Control and Complications Trial. Am J Clin Nutr (2008) 1.19
Macronutrient intake and discrepancy with nutritional recommendations in a group of elderly diabetic subjects. Br J Nutr (2007) 0.91
Association of physical activity with all-cause mortality and incident and prevalent cardiovascular disease among patients with type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetologia (2012) 0.90
Relation of the Mediterranean diet with the incidence of gestational diabetes. Eur J Clin Nutr (2013) 0.90
Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients: the EURODIAB Prospective Complications Study. Diabetologia (2012) 0.90
Dietary intake in Japanese patients with type 2 diabetes: Analysis from Japan Diabetes Complications Study. J Diabetes Investig (2013) 0.87
The diet of diabetic patients in Spain in 2008-2010: accordance with the main dietary recommendations--a cross-sectional study. PLoS One (2012) 0.83
Do European people with type 1 diabetes consume a high atherogenic diet? 7-year follow-up of the EURODIAB Prospective Complications Study. Eur J Nutr (2012) 0.78
Can health promotion model constructs predict nutritional behavior among diabetic patients? J Res Med Sci (2013) 0.78
Factors associated with dietary diversity score among individuals with type 2 diabetes mellitus. J Health Popul Nutr (2014) 0.77
Association of high carbohydrate versus high fat diet with glycated hemoglobin in high calorie consuming type 2 diabetics. J Diabetes Metab Disord (2013) 0.75
Higher dietary salt intake is associated with microalbuminuria, but not with retinopathy in individuals with type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetologia (2014) 0.75
Association of diet and lifestyle with glycated haemoglobin in type 1 diabetes participants in the EURODIAB prospective complications study. Eur J Clin Nutr (2015) 0.75
Involving consumers in research and development agenda setting for the NHS: developing an evidence-based approach. Health Technol Assess (2004) 4.59
Minor surgery in general practice. Br J Gen Pract (1990) 2.81
In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother (2001) 2.79
A desktop guide for the management of non-insulin-dependent diabetes mellitus (NIDDM): an update. European NIDDM Policy Group. Diabet Med (1994) 2.78
Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis (2004) 2.77
Teaching critical appraisal skills in health care settings. Cochrane Database Syst Rev (2001) 2.57
Dehalobacter restrictus gen. nov. and sp. nov., a strictly anaerobic bacterium that reductively dechlorinates tetra- and trichloroethene in an anaerobic respiration. Arch Microbiol (1998) 2.53
Management of non-insulin-dependent diabetes mellitus in Europe: a concensus view. Diabet Med (1988) 2.27
Complete protein sequence and identification of structural domains of human apolipoprotein B. Nature (1986) 2.12
Involving consumers in a needs-led research programme: a pilot project. Health Expect (2001) 2.10
Research in practice. Getting a grip. Health Serv J (1994) 1.97
Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care (1997) 1.84
Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabet Med (1992) 1.80
Reductive dehalogenation as a respiratory process. Antonie Van Leeuwenhoek (1994) 1.77
Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet (1993) 1.68
Functional domains of Bacillus thuringiensis insecticidal crystal proteins. Refinement of Heliothis virescens and Trichoplusia ni specificity domains on CryIA(c). J Biol Chem (1991) 1.66
Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia (1995) 1.63
The future of healthcare systems. Method for rigorously assessing cost effectiveness of new drugs must be set up. BMJ (1997) 1.59
Epidemiological evidence for the non-random clustering of the components of the metabolic syndrome: multicentre study of the Mediterranean Group for the Study of Diabetes. Eur J Clin Nutr (2006) 1.51
Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med (1993) 1.51
Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. J Clin Invest (1996) 1.49
Apolipoprotein D. Biochim Biophys Acta (2000) 1.48
Autoantibodies to the islet antigen ICA69 occur in IDDM and in rheumatoid arthritis. Diabetologia (1995) 1.48
The type and quality of randomized controlled trials (RCTs) published in UK public health journals. J Public Health Med (1995) 1.46
Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabet Med (1998) 1.43
Changes in brainstem auditory evoked potentials during insulin-induced hypoglycaemia in type 1 diabetic patients. Diabet Med (1991) 1.39
Recombinant growth hormone for idiopathic short stature in children and adolescents. Cochrane Database Syst Rev (2007) 1.35
Exercise-induced fall of blood glucose in insulin-treated diabetics unrelated to alteration of insulin mobilization. Diabetes (1979) 1.33
Assessment of small and large fiber function in long-term type 1 (insulin-dependent) diabetic patients with and without painful neuropathy. Pain (1988) 1.28
Cutaneous features of pseudoxanthoma elasticum in a patient with generalized arterial calcification of infancy due to a homozygous missense mutation in the ENPP1 gene. Br J Dermatol (2012) 1.27
The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group. J Diabetes Complications (1992) 1.27
Drinking goal selection in behavioral self-management treatment of chronic alcoholics. Addict Behav (1997) 1.24
Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost (1991) 1.19
Metabolic and hormonal effects of muscular exercise in juvenile type diabetics. Diabetologia (1977) 1.17
Recombinant growth hormone for children and adolescents with Turner syndrome. Cochrane Database Syst Rev (2007) 1.13
Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease. Diabetes (1997) 1.13
Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials. Exp Clin Endocrinol Diabetes (1999) 1.13
Smoking, alcohol and the risk of Dupuytren's contracture. J Bone Joint Surg Br (1997) 1.13
Visceral afferent neuropathy in diabetic gastroparesis. Diabetes Care (1991) 1.13
PTCA: periprocedural platelet activation. Part II of the Duesseldorf PTCA platelet study (DPPS) Eur Heart J (1996) 1.12
Evidence for abnormal platelet glycoprotein expression in diabetes mellitus. Eur J Clin Invest (1990) 1.11
Publication rate for funded studies from a major UK health research funder: a cohort study. BMJ Open (2013) 1.11
Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients. J Neurochem (1998) 1.11
Glycemic index in the diet of European outpatients with type 1 diabetes: relations to glycated hemoglobin and serum lipids. Am J Clin Nutr (2001) 1.10
Consumer health information needs to be rigorous, complete, and relevant. BMJ (2000) 1.10
Disease-modifying drugs for multiple sclerosis: a rapid and systematic review. Health Technol Assess (2000) 1.08
Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size. J Biol Chem (1994) 1.07
Evaluation of thermal, pain, and vibration sensation thresholds in newly diagnosed type 1 diabetic patients. J Neurol Neurosurg Psychiatry (1988) 1.06
Positron emission tomography: establishing priorities for health technology assessment. Health Technol Assess (1999) 1.06
Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects. Z Gastroenterol (1994) 1.05
Hepatic production of VLDL-triglycerides. Dependence of portal substrate and insulin concentration. Horm Metab Res (1980) 1.04
Dietary-induced hypertrophic--hyperplastic obesity in mice. J Lipid Res (1974) 1.04
Noninvasive blood glucose sensors based on near-infrared spectroscopy. Artif Organs (1994) 1.04
[13C]octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function. Diabetologia (1996) 1.01
A rapid and systematic review of the effectiveness of temozolomide for the treatment of recurrent malignant glioma. Br J Cancer (2002) 1.00
Keeping pace with new technologies: systems needed to identify and evaluate them. BMJ (1999) 0.99
What are the relative merits of the sources used to identify potential research priorities for the NHS HTA programme? Int J Technol Assess Health Care (2000) 0.98
Immunoelectron microscopy of low density lipoproteins yields a ribbon and bow model for the conformation of apolipoprotein B on the lipoprotein surface. J Lipid Res (1995) 0.97
Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation (1993) 0.97
Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy. Diabetes (1997) 0.96
Trends in cervical cancer mortality. Lancet (1991) 0.96
Effects of the carnitine-acyltransferase inhibitor etomoxir on insulin sensitivity, energy expenditure and substrate oxidation in NIDDM. Horm Metab Res (1997) 0.95
Flow-cytometric detection of surface membrane alterations and concomitant changes in the cytoskeletal actin status of activated platelets. Cytometry (1990) 0.95
Methylphenidate in children with hyperactivity: review and cost-utility analysis. Pharmacoepidemiol Drug Saf (2001) 0.94
Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. The Diacan Multicenter Study Group. Diabete Metab (1993) 0.94
The epidemiology of diabetic neuropathy. DiaCAN Multicenter Study Group. Diabet Med (1993) 0.94
Cost utility of drugs for multiple sclerosis. Systematic review places study in contrast. BMJ (2000) 0.94
Clinical effectiveness and cost-effectiveness of growth hormone in children: a systematic review and economic evaluation. Health Technol Assess (2002) 0.93
Challenges in quantifying biosphere-atmosphere exchange of nitrogen species. Environ Pollut (2007) 0.93
Blood amine acid levels in patients with insulin excess (functioning insulinoma) and insulin deficiency (diabetic ketosis). Metabolism (1978) 0.93
Characterization of the antitumor activity of hexadecylphosphocholine (D 18506). Eur J Cancer Clin Oncol (1988) 0.92
HLA antigens and immunoresponsiveness to insulin in insulin-dependent diabetes mellitus. Tissue Antigens (1976) 0.92
Evidence of IgG autoantibodies against human proinsulin in patients with IDDM before insulin treatment. Diabetes (1988) 0.92
The effectiveness and cost-effectiveness of temozolomide for the treatment of recurrent malignant glioma: a rapid and systematic review. Health Technol Assess (2001) 0.92
Carbohydrate sources and glycaemic control in Type 1 diabetes mellitus. EURODIAB IDDM Complications Study Group. Diabet Med (2000) 0.92
Police officers' perceptions of eyewitness performance in forensic investigations. J Soc Psychol (1998) 0.92
rhDNase therapy for the treatment of cystic fibrosis patients with mild to moderate lung disease. J Clin Pharm Ther (1999) 0.91
Binding of an antibody mimetic of the human low density lipoprotein receptor to apolipoprotein E is governed through electrostatic forces. Studies using site-directed mutagenesis and molecular modeling. J Biol Chem (2000) 0.91
Glucose metabolism in perfused skeletal muscle. Demonstration of insulin resistance in the obese Zucker rat. Biochem J (1979) 0.91
The natural course of peripheral and autonomic neural function during the first two years after diagnosis of type 1 diabetes. Klin Wochenschr (1988) 0.91
Raman spectroscopy-compatible inactivation method for pathogenic endospores. Appl Environ Microbiol (2010) 0.90
A Delphi study to establish national cost-effectiveness research priorities for positron emission tomography. Eur J Radiol (1999) 0.90
Bacterial cytochrome c nitrite reductase: new structural and functional aspects. J Inorg Biochem (2000) 0.90
Relation of fibre intake to HbA1c and the prevalence of severe ketoacidosis and severe hypoglycaemia. EURODIAB IDDM Complications Study Group. Diabetologia (1998) 0.89
Contaminated environments in the subsurface and bioremediation: organic contaminants. FEMS Microbiol Rev (1997) 0.89
Association of elevated serum uric acid with coronary heart disease in diabetes mellitus. Diabete Metab (1993) 0.89
Follow-up of cyclosporin A treatment in type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects. Diabetologia (1991) 0.89
Comparative toxicity of the HD-1 and NRD-12 strains of Bacillus thuringiensis subsp. kurstaki to defoliating forest Lepidoptera. J Invertebr Pathol (1992) 0.89
Impact of the NHS reforms on English hospital productivity: an analysis of the first three years. BMJ (1997) 0.89
Proinsulin autoantibodies are more closely associated with type 1 (insulin-dependent) diabetes mellitus than insulin autoantibodies. Diabetologia (1991) 0.88
Cerebral glucose metabolism in type 1 diabetic patients. Diabet Med (1994) 0.88
Prescription drug use and costs among diabetic patients in primary health care practices in Germany. Diabetes Care (1998) 0.87
The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1991) 0.87
Differences in the development of the obese-hyperglycemic syndrome in obob and NZO mice. Diabetologia (1970) 0.87
Systematic review of immunomodulatory drugs for the treatment of people with multiple sclerosis: Is there good quality evidence on effectiveness and cost? J Neurol Neurosurg Psychiatry (2001) 0.87
Computer virus infection. Lancet (1992) 0.86
Platelets in diabetes: the role in the hemostatic regulation in atherosclerosis. Semin Thromb Hemost (1993) 0.86